[{"Assets_0_Q1_USD":95498000.0,"CommonStockSharesConverted_0_Q1_shares":3423853.0,"CommonStockSharesOutstanding_0_Q1_shares":3423853.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-10188000.0,"NetIncomeLossConverted_1_Q1_USD":-13547000.0,"StockholdersEquity_0_Q1_USD":-60005000.0,"EarningsPerShareBasic_1_Q1_USD":-3.97,"Ticker":"TPTX","CIK":"1595893","name":"TURNING POINT THERAPEUTICS, INC.","OfficialName":"Turning Point Therapeutics Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1579986704.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190531"}]